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Fig. S1 Main effect filter analysis - underlying linkage disequilibrium (LD) structure of SNPs within pairwise interactions (P-value < 
0.05) associated with LDL cholesterol level. LD diagram was generated using Haploview!!
!!! !
Fig. S2 Main effect filter analysis - underlying linkage disequilibrium (LD) structure of SNPs within pairwise interactions (P-value < 
0.05) associated with total cholesterol level. LD diagram was generated using Haploview       !!
!!! !
Fig. S3 Main effect filter analysis - underlying linkage disequilibrium (LD) structure of SNPs within pairwise interactions (P-value < 
0.05) associated with triglyceride level. LD diagram was generated using Haploview !!
!
Fig. S4 Biofilter analysis - underlying linkage disequilibrium (LD) structure of SNPs within pairwise interactions (P-value < 0.05) 




Fig. S5 Biofilter analysis - underlying linkage disequilibrium (LD) structure of SNPs within pairwise interactions (P-value < 0.05) 
associated with LDL cholesterol level. LD diagram showing r2 values was generated using Haploview 
 
 !
Fig. S6 Biofilter analysis - underlying linkage disequilibrium (LD) structure of SNPs within pairwise interactions (P-value < 0.05) 
associated with total cholesterol level. LD diagram showing r2 values was generated using Haploview!
 
 !!!! !
Fig. S7 Biofilter analysis - underlying linkage disequilibrium (LD) structure of SNPs within pairwise interactions (P-value < 0.05) 
associated with triglyceride level. LD diagram showing r2 values was generated using Haploview!!
!!!! !
Table S1 Known biological roles of genes identified within SNP-SNP interactions associated with each lipid trait. Gene 
information found using GeneCards database (www.genecards.org, Accessed March 28, 2015) 
  
Gene Biological Role 
Main effect filter: HDL-C 
CETP Involved in the transfer of cholesteryl ester from HDL to other lipoproteins. 
PDE4B 
Belongs to the cyclic phosphodiesterase faily. Hydrolyzes cAMP, which is a key regulator of 
various physiological processes.  
NFKB1 
Encodes for the DNA binding subunit of the NFKB complex. NFKB activates multiple immune 
response genes. 
COX6B2 
Encodes for subunit 6B2 of cytochrome C oxidase, an enzyme that is a part of mitochondrial 
respiration. 
LPL 
 Mutations in LPL can cause type 1 hyperlipoproteinemia and other lipoprotein metabolism 
disorders. 
PSRC1 Involved in microtubule dynamics and mitotuc spindle organization.  
DAG1 
It is a part of the dystrophin-glycoprotein complex which provides a linkage between the 
cytoskeleton and extracellular matrix. 
STAB1 
Encodes for a transmembrane scavenger receptor protein that endocytoses low density 
lipoprotein. 
MBL2 Encodes for mannose-binding lectin that is a part of the innate immune system. 
FANCB Associated with the recessive disorder Fanconi Anemia.   
IDS Mutations in this gene cause a lysosomal storage disease called Hunter syndrome. 
Main effect filter: LDL-C   
TOMM40 
Encodes for a membrane protein required for transport into the mitochondria. Has been 
associated with increased risk of Alzheimer's disease and shown to affect LDL-C levels.   
C7orf10 Mutations in this gene are associated with glutaric aciduria type III.    
PDE3A 
Encodes for a cGMP inhibited phosphodiesterase, involved in platelet aggregation, cardiac 
contracility, hormone secretion, etc.    
KL 
Encodes for a transmembrane protein which has decreased expression in patients with chronic 
kidney disease   
APOE 
Encodes for apolipoprotein E which binds the LDL receptor and is involved in lipoprotein 
formation, sterol transport and cholesterol homeostasis.   
CETP Involved in the transfer of cholesteryl ester from HDL to other lipoproteins.   
GATAD2A Encodes for a zinc finger domain containing protein that acts as a transcriptional repressor.   
BCL3 
A candidate proto-oncogene, that is associated with the regulation of transcriptional activation of 
NFκB target genes.   
PCSK9 Encodes for an enzyme that is an attractive drug target for hypercholesterolemia.   
Main effect filter: TC   
APOB Mutations within this gene can cause an inherited form of hypercholesterolemia. 
LIPC Encodes for hepatic lipase which is involved in lipoprotein metabolism.   
ALDH2 
Encodes for aldehyde dehydrogenase that is involved in alchohol metabolism. Has been found to 
interact with genes involved in maintaining mitochondrial cholesterol levels. A polymorphism 
within this gene has been shown to be associated with HDL-C. 
  
ACAN Forms a part of the extracellular matrix in cartilagenous tissues.   
BCKDK 
Involved in the inactivation of a key enzyme of the valine, leucine and isoleucine catabolic 
pathways.   
Main effect filter: TG   
BUD13 
Originally discovered as a splicing factor in yeast, that is involved in nuclear pre-mRNA 
retention.    
GALNT2 
Encodes for a member of the GalNAc-transferase family, that catalyzes the initial reaction in O-
linked oligosaccharide biosynthesis.   
FADS3 
Member of the fatty acid desaturase gene family. Encodes for enzymes that regulate the 
unsaturation of fatty acids.   
APOA5 Encodes for an apolipoprotein that maintains plasma triglyceride levels.   
LIPA 
Encodes for a cholesterol ester hydrolase involved in the hydrolysis of triglycerides within 
lysosomes.   
KIAA0999 Encodes for a serine-threonine protein kinase that is a part of the SIK family.   
ZNF259 
Encodes for a zinc finger protein. Variants on this gene have been found to be associated with 
total choelsterol and triglycerides in the past.   
Biofilter: HDL-C   
HLA-DRA  
Encodes for a member of the HLA-DR class of molecules that are a part of the major 
histocompatibility complex.   
GGNBP1 Pseudogene of unknown function.   
HLA-DRB1 
Encodes for a member of the HLA-DR class of molecules that are a part of the major 
histocompatibility complex.   
BCL2  
A proto-oncogene that suppresses apoptosis. Altering cholesterol levels in the plasma membrane 
have been shown to affect BCL2 gene expression.    
Biofilter: LDL-C   
RIPK2 Encodes for a serine-threonine kinase that is a part of the receptor interacting protein family.   
STAT1 
Encodes for a transcription factor that belongs to the signal transducer and transcription activator 
family. It is also involved in the IL-6 signaling pathways involved in inflammation, immune 
regulation and oncogenesis. Oxidized LDL has been shown to activate STAT1.  
  
CYLD Encodes for a cytoplasmic protein involved in ubiquitination.   
STAT3 
Encodes for a transcription factor that belongs to the signal transducer and transcription activator 
family. It is also involved in the IL-6 signaling pathways involved in inflammation, immune 
regulation and oncogenesis. Oxidized LDL has been shown to activate STAT1.  
  
Biofilter: TC   
PRKAG2  PRKAG2 encodes for the regulatory γ2 subunit of an AMP-activated protein kinase.   
MLL2  Encodes for a mixed-lineage leukemia histone methylase.   
Biofilter: TG   
IRS2 Encodes for the insulin receptor substrate 2 molecule that mediates the effects of insulin.   
EGFR 
Encodes for the epidermal growth factor receptor. Cholesterol levels in the plasma membrane 
have been shown to regulate EGFR activity.    
APOA5 Encodes for an apolipoprotein that maintains plasma triglyceride levels.   
INSR Encodes for the insulin receptor molecule.   
GRB2 Encodes for the growth factor receptor binding protein.   
KIAA0999 Encodes for a serine-threonine protein kinase that is a part of the SIK family   
  
    
 
 
Table S2 Information for cohorts providing individual level data 
    Cohort No.  Cohort Name Geographic Location No. of Samples 
1 ARIC Washington County, MD; Forsyth County, NC; Jackson, MS; and Minneapolis, MN 9588 
2 CARDIA Birmingham, AL; Minneapolis, MN; Chicago, IL; and Oakland, CA 1443 
4 CHS Sacramento, CA; Hagerstown, MD; Winston-Salem, NC; and Pittsburgh, PA 3952 
5 FHS Framingham, MA 7556 
6 MESA New York, NY; Baltimore, MD; Chicago, IL; Los Angeles, CA; Twin Cities, MN; and Winston-Salem, NC 2298 
        
  Total Samples 24837 ! !
Table S3 Information of eMERGE cohorts providing individual level data for 
replication analyses 
   Site Name Geographic Location  No. in Sample 
   
HDL-C 
   Group Health Cooperative Seattle, WA 1861 
Vanderbilt University Nashville, TN 552 
Marshfield Clinic Stevens Point, WI 2100 
Mayo Clinic Rochester, MN 1447 
Northwestern University Evanston, IL 624 
   
  Total Sample Size 6584 
   LDL-C 
   Group Health Cooperative Seattle, WA 959 
Vanderbilt University Nashville, TN 578 
Marshfield Clinic Stevens Point, WI 1929 
Mayo Clinic Rochester, MN 1477 
Northwestern University Evanston, IL 553 
      
 
Total Sample Size 5496 
   TC 
   Group Health Cooperative Seattle, WA 1886 
Vanderbilt University Nashville, TN 583 
Marshfield Clinic Stevens Point, WI 2832 
Mayo Clinic Rochester, MN 1489 
Northwestern University Evanston, IL 632 
      
 
Total Sample Size 7422 
   TG 
   Group Health Cooperative Seattle, WA 1127 
Vanderbilt University Nashville, TN 586 
Marshfield Clinic Stevens Point, WI 2184 
Mayo Clinic Rochester, MN 1495 
Northwestern University Evanston, IL 625 
      
 
Total Sample Size 6017 ! !
Table S4 Number of original (non-proxy) and LD-expanded (proxy) SNP-
SNP models tested for replication in eMERGE dataset. Numbers are shown 
for each lipid trait after using both filtering methods 
     
 
No. of original SNP-
SNP models tested 
No. of LD-expanded 
models tested  
Main effect filter: HDL-C 4 114 
Main effect filter: LDL-C 2 23 
      Main effect filter: TC 0 24 
      Main effect filter: TG 2 15 
            Biofilter: HDL-C 0 3 
             Biofilter: LDL-C 0 305 
                    Biofilter: TC 0 8 
                    Biofilter: TG 8 56 ! !
Table S5 Number of LD-expanded (proxy) SNP-SNP models generated for each original discovered SNP-SNP model. Also shown 
are the number of SNP-SNP models tested for replication in eMERGE dataset per signal. Numbers are shown for each lipid trait after 
using both main effect and Biofilter filtering methods 
   
Original discovered model No. of additional LD expanded models generated 
No. of LD-expanded models tested for 
replication in eMERGE 
Main effect filter: HDL-C 
rs4783961,rs1800775 9 7 
rs12720918,rs158477 1 0 
rs4783961,rs1864163 0 1 
rs12720918,rs4783961 2 0 
rs1864163,rs4784744 4 3 
rs12708967,rs820299 1 0 
rs12447924,rs9939224 39 0 
rs4783961,rs158477 0 0 
rs1864163,rs158477 0 0 
rs1864163,rs820299 0 0 
rs4783961,rs9939224 7 1 
rs1800775,rs820299 9 0 
rs12744291,rs1010554 97 4 
rs230541,rs4935047 159 80 
rs12976922,rs2952101 7 0 
rs9644636,rs7013777 25 15 
rs9939224,rs4784744 39 3 
rs599839,rs2952101 8 0 
rs12708967,rs158477 1 0 
rs3870336,rs6641322 1 0 
Main effect filter: LDL-C 
rs157580,rs439401 0 1 
rs17435152,rs3764261 29 0 
rs157580,rs405509 1 1 
rs12811752,rs1469713 215 0 
rs480780,rs2965174 35 21 
rs625619,rs3764261 9 0 
Main effect filter: TC 
rs693,rs661665 31 0 
rs12898801,rs953065 4 0 
rs10744777,rs749767 131 24 
Main effect filter: TG 
rs2075295,rs6589568 0 0 
rs4938303,rs180327 5 0 
rs180327,rs2075295 1 2 
rs180327,rs10750097 1 0 
rs11216129,rs10750097 7 0 
rs609526,rs12257915 20 0 
rs2075295,rs10750097 0 0 
rs4938303,rs6589568 2 0 
rs174455,rs689243 63 11 
rs180327,rs618923 3 2 
Biofilter: HDL-C 
rs17496549,rs615672 51 0 
rs549888,rs7240326 41 3 
Biofilter: LDL-C 
rs39499,rs751919 1539 261 
rs12693591,rs8072566 83 11 
rs2066795,rs8074524 83 11 
Biofilter: TC 
rs4725431,rs10875915 11 8 
Biofilter: TG 
rs9521510,rs2860184 20 0 
rs9521510,rs6510976 41 22 
rs2075110,rs4789172 11 6 
rs4773088,rs4804404 19 6 
rs7999797,rs8109559 11 7 
rs4771646,rs4804404 69 15 
rs1729409,rs11216162 15 0 
rs7999797,rs7252268 11 7 
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